imipramine has been researched along with Granulomatous Disease, Chronic in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Granulomatous Disease, Chronic: A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Trush, MA | 1 |
Van Dyke, K | 1 |
Wilson, ME | 1 |
Reasor, MJ | 1 |
1 other study available for imipramine and Granulomatous Disease, Chronic
Article | Year |
---|---|
Chemiluminescence resulting from an interaction between imipramine and human polymorphonuclear leukocytes.
Topics: Amitriptyline; Animals; Cell-Free System; Child; Drug Synergism; Granulomatous Disease, Chronic; Hum | 1977 |